Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE
about
Periodontal disease associated with amegakaryocytic thrombocytopenia in systemic lupus erythematosus.Effect of drug therapy on circulating and synovial fluid Ig-secreting cells in rheumatoid arthritis.Risk factors in the pregnancy of patients with systemic lupus erythematosus: association of hypocomplementaemia with poor prognosis.A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLEAnti-DNA antibody production by CD5+ and CD5- B cells of patients with systemic lupus erythematosus.Polyclonal B cell activation in lupus-prone mice precedes and predicts the development of autoimmune disease.Abnormalities of B-cell activation and immunoregulation in patients with Crohn's disease.Guinea pigs with inherited deficiencies of complement components C2 or C4 have characteristics of immune complex disease.Studies of the pathogenesis of angioimmunoblastic lymphadenopathyEnhancement of the impaired autologous mixed leukocyte reaction in patients with systemic lupus erythematosusA defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibodySpontaneous immunoglobulin A secretion and lack of mitogen-responsive B cells in systemic lupus erythematosusInduction of excessive B cell proliferation and differentiation by an in vitro stimulus in culture in human systemic lupus erythematosus.Inhibition of soluble antigen-induced T cell proliferation by warm-reactive antibodies to activated T cells in systemic lupus erythematosus.Analysis of anticentromere autoantibodies using cloned autoantigen CENP-B.B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels.In vitro nucleoside specific immune response by lymphocytes from systemic lupus erythematosusAnimal models of human systemic lupus erythematosusAnti-Ia reactivity in sera from patients with systemic lupus erythematosus.Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets.Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulationsDepressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus.A serum inhibitor of immune regulation in patients with systemic lupus erythematosus.Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.Diminished response to an inhibitory signal in lymphocytes from patients with systemic lupus erythematosus.Impaired tumour necrosis factor-alpha (TNF-alpha) production and abnormal B cell response to TNF-alpha in patients with systemic lupus erythematosus (SLE).B-B cell interactions in the spontaneous activation of B cells in autoimmune NZB mice.TGF-β-Induced CD8+CD103+ Regulatory T Cells Show Potent Therapeutic Effect on Chronic Graft-versus-Host Disease Lupus by Suppressing B Cells.
P2860
Q33482881-D3DDAA42-6A75-44F2-9328-89A6BF14F062Q33555805-3E5C97BD-D896-46B7-96A5-0C753BF80549Q33567589-0927D7CE-037F-4E90-80CB-7669E82BF1D9Q33614719-ABA94026-64EB-478E-BC3D-76FCDA8EEF34Q34240804-D2077124-5DFE-4B1B-A14C-061467BC3E3DQ34261883-02EF1C81-DAEB-41E9-981A-9443CDBB391EQ34525339-ED344891-6C61-492D-ADCE-3C4AD687E604Q34537829-8DE8157C-6289-4F51-812B-0B1405DE0AB1Q34544422-89AEAFD2-312D-4FCC-B91B-5BD1AD4800C4Q34550034-481DED0D-FD75-4387-8F1E-A063B8AAC6C7Q34563462-880805F6-35A7-4260-ADD6-E59FD1E4F589Q34564739-18A7A4CA-3B80-4EB5-AA52-69D0629B3B2DQ34568623-4221B274-BB35-469E-BDCE-E637070E65E6Q34621296-F158319C-3130-4D99-A708-2F220E20E05BQ34640200-D242E6F5-85A4-4A0F-B758-CF5B7CF1661CQ34895937-CF056AE0-9C66-4FD1-BECA-79BF8CBEFA6FQ35207072-8D95DABA-7DDB-40BC-A0E3-705C629475F5Q36998593-28A0B8FD-271F-4D6F-8760-389ABE363875Q37013627-06A48025-3706-45BC-969B-C83571568166Q37017080-167FAFCF-80E9-40AA-9A9F-947756175454Q37020805-11E2D32A-5381-42BE-9682-4604AD431C8EQ37024055-8EA56808-C448-46BF-B030-259685781095Q37025065-960711B4-A0D6-4A5C-AC65-6062686BEFD0Q37031963-FA895EF4-C6C1-4844-85E6-34E68EB2BCD9Q37038182-FCE6C144-B871-41EB-98B1-EA170D452F70Q41422980-7DBC20C7-3484-4C6F-AB31-B0C4478BE546Q43659678-F9BC4FC8-253C-4666-B932-62D8C9BDD5BBQ44621111-0E0F8859-A9D7-46C2-AA1D-67AD86B2DF7AQ49332393-0D96A09B-E6A7-4B41-A387-C83AFAA10C36
P2860
Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE
description
1977 nî lūn-bûn
@nan
1977 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1977 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
name
Increased spontaneous activity ...... od of patients with active SLE
@ast
Increased spontaneous activity ...... od of patients with active SLE
@en
Increased spontaneous activity ...... od of patients with active SLE
@nl
type
label
Increased spontaneous activity ...... od of patients with active SLE
@ast
Increased spontaneous activity ...... od of patients with active SLE
@en
Increased spontaneous activity ...... od of patients with active SLE
@nl
prefLabel
Increased spontaneous activity ...... od of patients with active SLE
@ast
Increased spontaneous activity ...... od of patients with active SLE
@en
Increased spontaneous activity ...... od of patients with active SLE
@nl
P2093
P356
P1476
Increased spontaneous activity ...... od of patients with active SLE
@en
P2093
A D Steinberg
D R Budman
E B Merchant
J P Reeves
P304
P356
10.1002/ART.1780200312
P407
P577
1977-04-01T00:00:00Z